{{Rsnum
|rsid=165774
|Gene=COMT
|Chromosome=22
|position=19965038
|Orientation=plus
|GMAF=0.2287
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=COMT
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 11.5 | 39.8 | 48.7
| HCB | 2.9 | 29.2 | 67.9
| JPT | 0.9 | 34.5 | 64.5
| YRI | 7.5 | 32.9 | 59.6
| ASW | 5.3 | 24.6 | 70.2
| CHB | 2.9 | 29.2 | 67.9
| CHD | 0.9 | 21.1 | 78.0
| GIH | 1.0 | 32.7 | 66.3
| LWK | 3.7 | 33.0 | 63.3
| MEX | 3.4 | 29.3 | 67.2
| MKK | 0.0 | 0.0 | 0.0
| TSI | 12.7 | 47.1 | 40.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=20934310
|Title=HapMap tag-SNP analysis confirms a role for COMT in schizophrenia risk and reveals a novel association
}}

{{PMID Auto
|PMID=17442488
|Title=An association study between cathechol-O-methyltransferase gene and mental retardation in the Chinese Han population.
}}

{{PMID Auto
|PMID=18436194
|Title=Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes.
|OA=1
}}

{{PMID Auto
|PMID=18937309
|Title=Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.
|OA=1
}}

{{PMID Auto
|PMID=19673036
|Title=Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population.
|OA=1
}}

{{PMID Auto
|PMID=21172166
|Title=Pharmacogenetics of antidepressant response.
|OA=1
}}

{{PMID Auto
|PMID=24320736
|Title=Role of single nucleotide polymorphisms in estrogen-metabolizing enzymes and susceptibility to uterine leiomyoma in Han Chinese: A case-control study
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}